114 related articles for article (PubMed ID: 12517502)
21. [Chemotherapy of patients with colorectal carcinoma].
Punt CJ
Ned Tijdschr Geneeskd; 2005 Jun; 149(26):1441-7. PubMed ID: 16010954
[TBL] [Abstract][Full Text] [Related]
22. Deleted in colorectal cancer protein expression as a possible predictor of response to adjuvant chemotherapy in colorectal cancer patients.
Gal R; Sadikov E; Sulkes J; Klein B; Koren R
Dis Colon Rectum; 2004 Jul; 47(7):1216-24. PubMed ID: 15148649
[TBL] [Abstract][Full Text] [Related]
23. Adjuvant therapy for colorectal cancer: yesterday, today, and tomorrow.
Beaven AW; Goldberg RM
Oncology (Williston Park); 2006 Apr; 20(5):461-9; discussion 469-70, 473-5. PubMed ID: 16739745
[TBL] [Abstract][Full Text] [Related]
24. Targeting the epidermal growth factor receptor in colorectal cancer: advances and controversies.
Italiano A
Oncology; 2006; 70(3):161-7. PubMed ID: 16675911
[TBL] [Abstract][Full Text] [Related]
25. Adjuvant therapy with the monoclonal antibody Edrecolomab plus fluorouracil-based therapy does not improve overall survival of patients with stage III colon cancer.
Fields AL; Keller A; Schwartzberg L; Bernard S; Kardinal C; Cohen A; Schulz J; Eisenberg P; Forster J; Wissel P
J Clin Oncol; 2009 Apr; 27(12):1941-7. PubMed ID: 19273708
[TBL] [Abstract][Full Text] [Related]
26. [Detection of hepatic micrometastases in the context of adjuvant chemotherapy and surgery for hepatic metastases].
Schimanski CC; Möhler M; Zimmermann T; Gockel I; Lang H; Arbogast R; Jäger D; Galle PR; Berger MR
Dtsch Med Wochenschr; 2010 May; 135(21):1078-82. PubMed ID: 20486059
[TBL] [Abstract][Full Text] [Related]
27. The use of bevacizumab in colorectal, lung, breast, renal and ovarian cancer: where does it fit?
Eskens FA; Sleijfer S
Eur J Cancer; 2008 Nov; 44(16):2350-6. PubMed ID: 18789679
[TBL] [Abstract][Full Text] [Related]
28. Cetuximab in the treatment of colorectal cancer.
Goldberg RM; Venook AP; Schilsky RL
Clin Adv Hematol Oncol; 2004 Nov; 2(11):1-10; quiz 11-12. PubMed ID: 16170891
[No Abstract] [Full Text] [Related]
29. Cetuximab targeted therapy: a new treatment paradigm for advanced colorectal cancer.
Chu E
Clin Colorectal Cancer; 2004 Feb; 3(4):205. PubMed ID: 15025791
[No Abstract] [Full Text] [Related]
30. New treatments for colon cancer.
Slevin M; Payne S
BMJ; 2004 Jul; 329(7458):124-6. PubMed ID: 15258046
[No Abstract] [Full Text] [Related]
31. [Two radically resected colorectal carcinoma cases with unresectable liver metastasis after adjuvant chemotherapy with bevacizumab].
Sugiyama M; Kakeji Y; Kubo N; Nakanoko T; Fujinaka Y; Ando K; Masuda T; Yagi K; Yoshinaga K; Saeki H; Endo K; Emi Y; Morita M; Maehara Y
Gan To Kagaku Ryoho; 2009 Nov; 36(12):2169-71. PubMed ID: 20037359
[TBL] [Abstract][Full Text] [Related]
32. [Adjuvant and palliative anticancer treatment of colon carcinoma in 2004].
Medinger M; Steinbild S; Mross K
Praxis (Bern 1994); 2004 Sep; 93(40):1633-44. PubMed ID: 15495753
[TBL] [Abstract][Full Text] [Related]
33. Panitumumab in colorectal cancer.
Wainberg ZA; Hecht JR
Expert Rev Anticancer Ther; 2007 Jul; 7(7):967-73. PubMed ID: 17627455
[TBL] [Abstract][Full Text] [Related]
34. PET concerns in bevacizumab treatment.
Goessl C; Grozdanovic Z
Nat Med; 2004 Jun; 10(6):561; author reply 561. PubMed ID: 15170192
[No Abstract] [Full Text] [Related]
35. [Monoclonal antibodies therapies for colorectal cancer: cétuximab, panitumumab and bevacizumab].
Piront P; Van Daele D; Belaiche J; Polus M
Rev Med Liege; 2009; 64(5-6):274-8. PubMed ID: 19642458
[TBL] [Abstract][Full Text] [Related]
36. The treatment of colorectal carcinoma: standard chemotherapy and beyond.
Eng C; Abbruzzese JL
Clin Adv Hematol Oncol; 2004 Sep; 2(9):592-8. PubMed ID: 16163242
[TBL] [Abstract][Full Text] [Related]
37. American Society of Clinical Oncology 2010 colorectal update.
Murphy JE; Ryan DP
Expert Rev Anticancer Ther; 2010 Sep; 10(9):1371-3. PubMed ID: 20836671
[TBL] [Abstract][Full Text] [Related]
38. [Efficacy of monoclonal antibodies in combination with chemotherapy in metastatic colorectal cancer].
Takiuchi H
Nihon Rinsho; 2011 Apr; 69 Suppl 3():459-63. PubMed ID: 22214004
[No Abstract] [Full Text] [Related]
39. Targeted therapy in colorectal carcinoma: more than a theory.
Pickering L; Rudman S; Ross PJ; Leslie MD
Colorectal Dis; 2008 Mar; 10(3):209-18; discussion 218-221. PubMed ID: 18257846
[TBL] [Abstract][Full Text] [Related]
40. Treatment paradigms with epidermal growth factor receptor-targeted therapies in colorectal cancer.
Stein S; Cohen DJ; Hochster HS
Clin Colorectal Cancer; 2010 Jun; 9 Suppl 1():S44-50. PubMed ID: 20630850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
